80 FR 52480 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 168 (August 31, 2015)

Page Range		52480-52480
FR Document		2015-21481

Federal Register, Volume 80 Issue 168 (Monday, August 31, 2015)

[Federal Register Volume 80, Number 168 (Monday, August 31, 2015)]
[Notices]
[Page 52480]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-21481]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID Investigator Initiated 
Program Project Applications (P01).
    Date: September 25 and 28, 2015.
    Time: September 25, 2015, 12:30 p.m. to 4:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health; Room 3F52B; 5601 Fishers 
Lane; Rockville, MD 20892; (Telephone Conference Call).
    Time: September 28, 2015, 9:30 a.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health; Room 3F52B; 5601 Fishers 
Lane; Rockville, MD 20892; (Telephone Conference Call).
    Contact Person: Nancy Vazquez-Maldonado, Ph.D., Scientific 
Review Officer; Scientific Review Program; Division of Extramural 
Activities, Room 3F52B; National Institutes of Health/NIAID; 5601 
Fishers Lane, MSC 9823; Bethesda, MD 20892-9823; (240) 669-5044; 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: August 26, 2015.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-21481 Filed 8-28-15; 8:45 am]
BILLING CODE 4140-01-P

52480 Federal Register / Vol. 80, No. 168 / Monday, August 31, 2015 / Notices

experimental data to support the (3) to exclude himself voluntarily Scientific Review Program; Division of
experimental hypothesis. Specifically: from serving in any advisory capacity to Extramural Activities, Room 3F52B; National
1. ORI found falsified and/or PHS including, but not limited to, Institutes of Health/NIAID; 5601 Fishers
Lane, MSC 9823; Bethesda, MD 20892–9823;
fabricated data in Paper 1 in: service on any PHS advisory committee,
(240) 669–5044; nv19q@nih.gov.
a. Figure 5B by manipulation of the board, and/or peer review committee, or
(Catalogue of Federal Domestic Assistance
HER3 protein concentrations in the as a consultant for period of three (3) Program Nos. 93.855, Allergy, Immunology,
experiment to provide the desired years beginning on August 4, 2015; and and Transplantation Research; 93.856,
outcome (4) to retraction or correction of the Microbiology and Infectious Diseases
b. Figure 6C for the identification of the following papers: Research, National Institutes of Health, HHS)
kinase domain construct EGFR– • Science Signaling 7:ra114, 2014 Dated: August 26, 2015.
V924R by falsely claiming that both • Chemistry & Biology 21:453–458,
David Clary,
EGFR and HER3 contained the kinase 2014
Program Analyst, Office of Federal Advisory
domains and the full JM segments, FOR FURTHER INFORMATION CONTACT: Committee Policy.
when the JM–HER3 construct Acting Director, Office of Research [FR Doc. 2015–21481 Filed 8–28–15; 8:45 am]
included cloning tags Integrity, 1101 Wootton Parkway, Suite BILLING CODE 4140–01–P
c. Figure 6D by manually manipulating 750, Rockville, MD 20852, (240) 453–
the error bars to increase statistical 8200.
significance of the kinase assay Donald Wright, DEPARTMENT OF HEALTH AND
2. ORI found falsified and/or Acting Director, Office of Research Integrity. HUMAN SERVICES
fabricated data in Paper 2 in: [FR Doc. 2015–21421 Filed 8–28–15; 8:45 am] National Institutes of Health
a. Figure 3C by manually altering some BILLING CODE 4150–31–P
of the data points by 10–20% support Center for Scientific Review; Notice of
the desired hypothesis Closed Meetings
b. Figure 4A by manipulating data DEPARTMENT OF HEALTH AND
points and reducing error bars and HUMAN SERVICES Pursuant to section 10(d) of the
failing to report that JM–HER3 Federal Advisory Committee Act, as
construct had cloning tags National Institutes of Health amended (5 U.S.C. App.), notice is
c. Figure 4B by reducing several data hereby given of the following meetings.
points by ∼ 15% National Institute of Allergy and The meetings will be closed to the
Infectious Diseases; Notice of Closed public in accordance with the
Mr. Littlefield has entered into a Meeting provisions set forth in sections
Voluntary Settlement Agreement and 552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
has voluntarily agreed: Pursuant to section 10(d) of the
as amended. The grant applications and
(1) To have his research supervised Federal Advisory Committee Act, as
the discussions could disclose
for period of three (3) years beginning amended (5 U.S.C. App.), notice is
confidential trade secrets or commercial
on August 4, 2015; Respondent agreed hereby given of the following meeting.
The meeting will be closed to the property such as patentable material,
that prior to the submission of an and personal information concerning
application for U.S. Public Health public in accordance with the
provisions set forth in sections individuals associated with the grant
Service (PHS) support for a research applications, the disclosure of which
project on which his participation is 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and would constitute a clearly unwarranted
proposed and prior to his participation invasion of personal privacy.
in any capacity on PHS-supported the discussions could disclose
research, Respondent shall ensure that a confidential trade secrets or commercial Name of Committee: Center for Scientific
property such as patentable material, Review Special Emphasis Panel; PAR Panel:
plan for supervision of his duties is Pregnancy in Women with Disabilities.
submitted to ORI for approval; the and personal information concerning
individuals associated with the grant Date: September 21, 2015.
supervision plan must be designed to Time: 2:00 p.m. to 4:00 p.m.
ensure the scientific integrity of his applications, the disclosure of which Agenda: To review and evaluate grant
research contribution; Respondent would constitute a clearly unwarranted applications.
agreed that he will not participate in invasion of personal privacy. Place: National Institutes of Health, 6701
any PHS-supported research until such Name of Committee: National Institute of Rockledge Drive, Bethesda, MD 20892
a supervision plan is submitted to and Allergy and Infectious Diseases Special (Telephone Conference Call).
approved by ORI; Respondent agreed to Emphasis Panel; NIAID Investigator Initiated Contact Person: Delia Olufokunbi Sam,
Program Project Applications (P01). Ph.D., Scientific Review Officer, Center for
maintain responsibility for compliance Scientific Review, National Institutes of
with the agreed upon supervision plan; Date: September 25 and 28, 2015.
Time: September 25, 2015, 12:30 p.m. to Health, 6701 Rockledge Drive, Room 3158,
(2) that for period of three (3) years 4:30 p.m. MSC 7770, Bethesda, MD 20892, 301–435–
beginning on August 4, 2015, any Agenda: To review and evaluate grant 0684, olufokunbisamd@csr.nih.gov.
institution employing him shall submit applications. Name of Committee: Emerging
in conjunction with each application for Place: National Institutes of Health; Room Technologies and Training Neurosciences
PHS funds, or report, manuscript, or 3F52B; 5601 Fishers Lane; Rockville, MD Integrated Review Group, Bioengineering of
abstract involving PHS-supported 20892; (Telephone Conference Call). Neuroscience, Vision and Low Vision
research in which Respondent is Time: September 28, 2015, 9:30 a.m. to Technologies Study Section.
2:00 p.m. Date: September 29, 2015.
tkelley on DSK3SPTVN1PROD with NOTICES

involved, a certification to ORI that the
data provided by Respondent are based Agenda: To review and evaluate grant Time: 8:00 a.m. to 6:00 p.m.
applications. Agenda: To review and evaluate grant
on actual experiments or are otherwise Place: National Institutes of Health; Room applications.
legitimately derived, and that the data, 3F52B; 5601 Fishers Lane; Rockville, MD Place: St. Gregory Luxury Hotel & Suites,
procedures, and methodology are 20892; (Telephone Conference Call). 2033 M Street NW., Washington, DC 20036.
accurately reported in the application, Contact Person: Nancy Vazquez- Contact Person: Robert C Elliott, Ph.D.,
report, manuscript, or abstract; Maldonado, Ph.D., Scientific Review Officer; Scientific Review Officer, Center for

VerDate Sep<11>2014 16:19 Aug 28, 2015 Jkt 235001 PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 E:\FR\FM\31AUN1.SGM 31AUN1

Document Created: 2018-02-23 11:04:45
Document Modified: 2018-02-23 11:04:45

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		September 25 and 28, 2015.
FR Citation		80 FR 52480

80 FR 52480 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 80, Issue 168 (August 31, 2015)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health